{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:56:06Z","timestamp":1794362166033,"version":"4.9.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:00:00Z","timestamp":1625702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2016\/21\/B\/NZ4\/00181"],"award-info":[{"award-number":["2016\/21\/B\/NZ4\/00181"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["665735"],"award-info":[{"award-number":["665735"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004569","name":"Ministerstwo Edukacji i Nauki","doi-asserted-by":"publisher","award":["3548\/H2020\/COFUND\/2016\/2"],"award-info":[{"award-number":["3548\/H2020\/COFUND\/2016\/2"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004569","name":"Ministerstwo Edukacji i Nauki","doi-asserted-by":"publisher","award":["K18\\u0394280"],"award-info":[{"award-number":["K18\\u0394280"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.bbadis.2021.166209","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T13:38:04Z","timestamp":1625751484000},"page":"166209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Neurotoxicity of oligomers of phosphorylated Tau protein carrying tauopathy-associated mutation is inhibited by prion protein"],"prefix":"10.1016","volume":"1867","author":[{"given":"Hanna","family":"Nieznanska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomiia","family":"Boyko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Dec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jolanta","family":"Redowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Dzwolak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Nieznanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2021.166209_bb0005","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1152\/physrev.00024.2003","article-title":"Role of tau protein in both physiological and pathological conditions","volume":"84","author":"Avila","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbadis.2021.166209_bb0010","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.1996.tb34407.x","article-title":"Structure, microtubule interactions, and phosphorylation of tau protein","volume":"777","author":"Mandelkow","year":"1996","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2021.166209_bb0015","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.neuron.2011.04.009","article-title":"The many faces of tau","volume":"70","author":"Morris","year":"2011","journal-title":"Neuron."},{"issue":"2","key":"10.1016\/j.bbadis.2021.166209_bb0020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/biom6020028","article-title":"NMR meets tau: insights into its function and pathology","volume":"6","author":"Lippens","year":"2016","journal-title":"Biomolecules."},{"key":"10.1016\/j.bbadis.2021.166209_bb0025","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2021.166209_bb0030","doi-asserted-by":"crossref","first-page":"7025","DOI":"10.1038\/ncomms8025","article-title":"A mechanistic model of tau amyloid aggregation based on direct observation of oligomers","volume":"6","author":"Shammas","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2021.166209_bb0035","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0896-6273(00)80615-7","article-title":"Tau mutations cause frontotemporal dementias","volume":"21","author":"Goedert","year":"1998","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.bbadis.2021.166209_bb0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13041-017-0298-7","article-title":"Propagation of Tau aggregates","volume":"10","author":"Goedert","year":"2017","journal-title":"Mol. Brain"},{"key":"10.1016\/j.bbadis.2021.166209_bb0045","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF00309621","article-title":"Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease","volume":"89","author":"Cras","year":"1995","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2021.166209_bb0050","doi-asserted-by":"crossref","first-page":"12845","DOI":"10.1074\/jbc.M808759200","article-title":"Propagation of tau misfolding from the outside to the inside of a cell","volume":"284","author":"Frost","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2021.166209_bb0055","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1016\/j.febslet.2006.07.078","article-title":"Extracellular tau is toxic to neuronal cells","volume":"580","author":"G\u00f3mez-Ramos","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2021.166209_bb0060","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/260787","article-title":"Trimeric tau is toxic to human neuronal cells at low nanomolar concentrations","volume":"2013","author":"Tian","year":"2013","journal-title":"Int. J. Cell Biol."},{"key":"10.1016\/j.bbadis.2021.166209_bb0065","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.conb.2015.09.004","article-title":"Tau neurotoxicity and rescue in animal models of human Tauopathies","volume":"36","author":"Kr\u00fcger","year":"2016","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.bbadis.2021.166209_bb0070","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.neures.2005.11.009","article-title":"Increased levels of granular tau oligomers: an early sign of brain aging and Alzheimer\u2019s disease","volume":"54","author":"Maeda","year":"2006","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.bbadis.2021.166209_bb0075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1326-6-39","article-title":"Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice","volume":"6","author":"Lasagna-Reeves","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbadis.2021.166209_bb0080","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/srep00700","article-title":"Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau","volume":"2","author":"Lasagna-Reeves","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2021.166209_bb0085","doi-asserted-by":"crossref","first-page":"19393","DOI":"10.1038\/srep19393","article-title":"Extracellular Tau oligomers produce an immediate impairment of LTP and memory","volume":"6","author":"F\u00e1","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2021.166209_bb0090","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1073\/pnas.94.1.298","article-title":"Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau","volume":"94","author":"Alonso","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2021.166209_bb0095","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/978-981-32-9358-8_27","article-title":"Tau oligomers","volume":"1184","author":"Maeda","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbadis.2021.166209_bb0100","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11427-006-2019-9","article-title":"Study on interaction between microtubule associated protein tau and prion protein","volume":"49","author":"Han","year":"2006","journal-title":"Sci China C Life Sci"},{"key":"10.1016\/j.bbadis.2021.166209_bb0105","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3233\/JAD-130566","article-title":"Impact of the cellular prion protein on amyloid-\u03b2 and 3PO-tau processing","volume":"38","author":"Schmitz","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2021.166209_bb0110","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11010-007-9664-6","article-title":"Human tau protein forms complex with PrP and some GSS- and fCJD-related PrP mutants possess stronger binding activities with tau in vitro","volume":"310","author":"Wang","year":"2008","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbadis.2021.166209_bb0115","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nature07761","article-title":"Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers","volume":"457","author":"Lauren","year":"2009","journal-title":"Nature."},{"key":"10.1016\/j.bbadis.2021.166209_bb0120","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","article-title":"Prions","volume":"95","author":"Prusiner","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2021.166209_bb0125","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1021\/bi900108v","article-title":"Prion diseases and their biochemical mechanisms","volume":"48","author":"Cobb","year":"2009","journal-title":"Biochemistry."},{"key":"10.1016\/j.bbadis.2021.166209_bb0130","doi-asserted-by":"crossref","first-page":"37743","DOI":"10.1074\/jbc.M105677200","article-title":"The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein","volume":"276","author":"Vincent","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbadis.2021.166209_bb0135","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1007\/s12035-014-8793-7","article-title":"Role of PrP(C) expression in tau protein levels and phosphorylation in Alzheimer\u2019s disease evolution","volume":"51","author":"Vergara","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbadis.2021.166209_bb0140","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1038\/srep04881","article-title":"A PrP(C)-caveolin-Lyn complex negatively controls neuronal GSK3\u03b2 and serotonin 1B receptor","volume":"4","author":"Hernandez-Rapp","year":"2014","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bbadis.2021.166209_bb0145","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3390\/cells9030591","article-title":"The quest for cellular prion protein functions in the aged and neurodegenerating brain","volume":"9","author":"Gav\u00edn","year":"2020","journal-title":"Cells."},{"key":"10.1016\/j.bbadis.2021.166209_bb0150","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1074\/jbc.M111.323626","article-title":"\u03b1-Secretase-derived fragment of cellular prion, N1, protects against monomeric and oligomeric amyloid \u03b2 (A\u03b2)-associated cell death","volume":"287","author":"Guillot-Sestier","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2021.166209_bb0155","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.nbd.2016.03.001","article-title":"Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by A\u03b2 oligomers: implications for novel therapeutic strategy in Alzheimer\u2019s disease","volume":"91","author":"Scott-McKean","year":"2016","journal-title":"Neurobiol. Dis."},{"issue":"6 Pt A","key":"10.1016\/j.bbadis.2021.166209_bb0160","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/j.bbadis.2018.03.023","article-title":"Identification of prion protein-derived peptides of potential use in Alzheimer\u2019s disease therapy","volume":"1864","author":"Nieznanska","year":"2018","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.bbadis.2021.166209_bb0165","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1021\/mp2005627","article-title":"Phosphorus dendrimers affect Alzheimer\u2019s (A\u03b21-28) peptide and MAP-Tau protein aggregation","volume":"9","author":"Wasiak","year":"2012","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.bbadis.2021.166209_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201182","article-title":"Amyloidogenic cross-seeding of Tau protein: transient emergence of structural variants of fibrils","volume":"13","author":"Nizynski","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2021.166209_bb0175","doi-asserted-by":"crossref","first-page":"36859","DOI":"10.1074\/jbc.274.52.36859","article-title":"Membrane environment alters the conformational structure of the recombinant human prion protein","volume":"274","author":"Morillas","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2021.166209_bb0180","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature."},{"key":"10.1016\/j.bbadis.2021.166209_bb0185","doi-asserted-by":"crossref","first-page":"32046","DOI":"10.1074\/jbc.M201750200","article-title":"Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability","volume":"277","author":"Dahlgren","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2021.166209_bb0190","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1021\/cn500143n","volume":"5","author":"Gerson","year":"2014","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.bbadis.2021.166209_bb0195","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/2051-5960-2-73","article-title":"Characterization of tau oligomeric seeds in progressive supranuclear palsy","volume":"2","author":"Gerson","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbadis.2021.166209_bb0200","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fnagi.2017.00083","article-title":"Tau oligomers: cytotoxicity, propagation, and mitochondrial damage","volume":"9","author":"Shafiei","year":"2017","journal-title":"Front. Aging Neurosci."},{"issue":"12","key":"10.1016\/j.bbadis.2021.166209_bb0205","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1021\/bi061359o","article-title":"Granular tau oligomers as intermediates of tau filaments","volume":"46","author":"Maeda","year":"2007","journal-title":"Biochemistry."},{"issue":"28","key":"10.1016\/j.bbadis.2021.166209_bb0210","doi-asserted-by":"crossref","first-page":"7393","DOI":"10.1021\/bi702466a","article-title":"A soluble oligomer of tau associated with fiber formation analyzed by NMR","volume":"47","author":"Peterson","year":"2008","journal-title":"Biochemistry."},{"issue":"2","key":"10.1016\/j.bbadis.2021.166209_bb0215","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1086\/302256","article-title":"High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands","volume":"64","author":"Rizzu","year":"1999","journal-title":"Am. J. Hum. Genet."},{"issue":"50","key":"10.1016\/j.bbadis.2021.166209_bb0220","doi-asserted-by":"crossref","first-page":"14885","DOI":"10.1021\/bi026469j","article-title":"Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments","volume":"41","author":"Barghorn","year":"2002","journal-title":"Biochemistry."},{"issue":"21","key":"10.1016\/j.bbadis.2021.166209_bb0225","doi-asserted-by":"crossref","first-page":"18421","DOI":"10.1074\/jbc.M110406200","article-title":"Identification of the heparan sulfate binding sites in the cellular prion protein","volume":"277","author":"Warner","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bbadis.2021.166209_bb0230","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1021\/ja106725p","article-title":"Heparin binding by murine recombinant prion protein leads to transient aggregation and formation of RNA-resistant species","volume":"133","author":"Vieira","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbadis.2021.166209_bb0235","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fneur.2013.00112","article-title":"Hyperphosphorylation-induced tau oligomers","volume":"4","author":"Iqbal","year":"2013","journal-title":"Front. Neurol."},{"issue":"17","key":"10.1016\/j.bbadis.2021.166209_bb0240","doi-asserted-by":"crossref","first-page":"7486","DOI":"10.1523\/JNEUROSCI.19-17-07486.1999","article-title":"cAMP-dependent protein kinase phosphorylations on tau in Alzheimer\u2019s disease","volume":"19","author":"Jicha","year":"1999","journal-title":"J. Neurosci."},{"issue":"32","key":"10.1016\/j.bbadis.2021.166209_bb0245","doi-asserted-by":"crossref","first-page":"23645","DOI":"10.1074\/jbc.M703269200","article-title":"Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis","volume":"282","author":"Hanger","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bbadis.2021.166209_bb0250","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1021\/bi981874p","article-title":"Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments","volume":"38","author":"Schneider","year":"1999","journal-title":"Biochemistry."},{"issue":"6","key":"10.1016\/j.bbadis.2021.166209_bb0255","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1046\/j.1471-4159.1998.71062465.x","article-title":"New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer\u2019s disease brain using nanoelectrospray mass spectrometry","volume":"71","author":"Hanger","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2021.166209_bb0260","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1091\/mbc.9.6.1495","article-title":"The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer\u2019s disease","volume":"9","author":"Illenberger","year":"1998","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbadis.2021.166209_bb0265","doi-asserted-by":"crossref","first-page":"20318","DOI":"10.1074\/jbc.M114.554725","article-title":"Stages and conformations of the Tau repeat domain during aggregation and its effect on neuronal toxicity","volume":"289","author":"Kumar","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2021.166209_bb0270","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.1021\/bi052530j","article-title":"The core of tau-paired helical filaments studied by scanning transmission electron microscopy and limited proteolysis","volume":"45","author":"von Bergen","year":"2006","journal-title":"Biochemistry."},{"issue":"49","key":"10.1016\/j.bbadis.2021.166209_bb0275","doi-asserted-by":"crossref","first-page":"34389","DOI":"10.1074\/jbc.M114.611368","article-title":"Oligomer formation of tau protein hyperphosphorylated in cells","volume":"289","author":"Tepper","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2021.166209_bb0280","doi-asserted-by":"crossref","first-page":"4260e4272","DOI":"10.1523\/JNEUROSCI.3192-13.2014","article-title":"Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles","volume":"34","author":"Castillo-Carranza","year":"2014","journal-title":"J. Neurosci."},{"issue":"14","key":"10.1016\/j.bbadis.2021.166209_bb0285","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1523\/JNEUROSCI.0587-07.2007","article-title":"Accumulation of pathological tau species and memory loss in a conditional model of tauopathy","volume":"27","author":"Berger","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2021.166209_bb0290","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1083\/jcb.118.3.573","article-title":"Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro","volume":"118","author":"Wille","year":"1992","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2021.166209_bb0295","doi-asserted-by":"crossref","first-page":"24978","DOI":"10.1074\/jbc.M501565200","article-title":"Sites of tau important for aggregation populate {beta}-structure and bind to microtubules and polyanions","volume":"280","author":"Mukrasch","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2021.166209_bb0300","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.1093\/hmg\/ddv351","article-title":"The twenty-four kDa C-terminal tau fragment increases with aging in tauopathy mice: implications of prion-like properties","volume":"24","author":"Matsumoto","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2021.166209_bb0305","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neurobiolaging.2018.04.014","article-title":"Frontotemporal dementia with Parkinsonism linked to chromosome-17 mutations enhance tau oligomer formation","volume":"69","author":"Maeda","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2021.166209_bb0310","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0021-9258(18)54055-2","article-title":"Phosphorylation of recombinant tau by cAMPdependent protein kinase","volume":"268","author":"Scott","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2021.166209_bb0315","doi-asserted-by":"crossref","first-page":"11776","DOI":"10.1016\/S0021-9258(17)32639-X","article-title":"Differential effect of phosphorylation and substrate modulation on tau\u2019s ability to promote microtubule growth and nucleation","volume":"269","author":"Brandt","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bbadis.2021.166209_bb0320","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00401-019-02053-5","article-title":"A\u03b2-induced acceleration of Alzheimer-related \u03c4-pathology spreading and its association with prion protein","volume":"138","author":"Gomes","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2021.166209_bb0325","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1212\/WNL.39.11.1453","article-title":"Neurofibrillary tangles and plaques with PrP-amyloid coexist in an affected family","volume":"39","author":"Ghetti","year":"1989","journal-title":"Neurology."},{"key":"10.1016\/j.bbadis.2021.166209_bb0330","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0006-8993(93)90226-D","article-title":"A68 is a component of paired helical filaments of Gerstmann-Str\u00e4ussler-Scheinker disease, Indiana kindred","volume":"616","author":"Tagliavini","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2021.166209_bb0335","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1365-2990.2008.00959.x","article-title":"Ultrastructural study of florid plaques in variant Creutzfeldt-Jakob disease: a comparison with amyloid plaques in kuru, sporadic Creutzfeldt-Jakob disease and Gerstmann-Str\u00e4ussler-Scheinker disease","volume":"35","author":"Sikorska","year":"2009","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.bbadis.2021.166209_bb0340","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-010-0691-0","article-title":"Tau, prions and A\u03b2: the triad of neurodegeneration","volume":"121","author":"Reiniger","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2021.166209_bb0345","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1073\/pnas.96.7.4046","article-title":"Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents","volume":"96","author":"Bons","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2021.166209_bb0350","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.neurobiolaging.2007.04.026","article-title":"Tauopathy in human and experimental variant Creutzfeldt-Jakob disease","volume":"29","author":"Giaccone","year":"2008","journal-title":"Neurobiol. Aging"},{"issue":"10","key":"10.1016\/j.bbadis.2021.166209_bb0355","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1117","article-title":"An autopsy report of three kindred in a Gerstmann-Str\u00e4ussler-Scheinker disease P105L family with a special reference to prion protein, tau, and beta-amyloid","volume":"8","author":"Ishizawa","year":"2018","journal-title":"Brain Behav."},{"key":"10.1016\/j.bbadis.2021.166209_bb0360","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00401-002-0547-3","article-title":"Hyperphosphorylated tau deposition parallels prion protein burden in a case of Gerstmann-Str\u00e4ussler-Scheinker syndrome P102L mutation complicated with dementia","volume":"104","author":"Ishizawa","year":"2002","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2021.166209_bb0365","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1042\/bj20021596","article-title":"Prion peptide induces neuronal cell death through a pathway involving glycogen synthase kinase 3","volume":"372","author":"P\u00e9rez","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2021.166209_bb0370","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10571-007-9224-3","article-title":"Role of cyclin-dependent kinase 5 in the neurodegenerative process triggered by amyloid-Beta and prion peptides: implications for Alzheimer\u2019s disease and prion-related encephalopathies","volume":"27","author":"Lopes","year":"2007","journal-title":"Cell. Mol. Neurobiol."},{"issue":"10","key":"10.1016\/j.bbadis.2021.166209_bb0375","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1007\/s12035-020-02025-x","article-title":"Tau protein as a new regulator of cellular prion protein transcription","volume":"57","author":"Lid\u00f3n","year":"2020","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.bbadis.2021.166209_bb0380","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/jnc.15040","article-title":"The uptake of tau amyloid fibrils is facilitated by the cellular prion protein and hampers prion propagation in cultured cells","volume":"155","author":"De Cecco","year":"2020","journal-title":"J. Neurochem."},{"issue":"50","key":"10.1016\/j.bbadis.2021.166209_bb0385","doi-asserted-by":"crossref","first-page":"10595","DOI":"10.1523\/JNEUROSCI.1700-18.2018","article-title":"Cellular prion protein mediates the disruption of hippocampal synaptic plasticity by soluble tau in vivo","volume":"38","author":"Ondrejcak","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2021.166209_bb0390","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/emboj.2011.86","article-title":"The cellular prion protein mediates neurotoxic signalling of beta-sheet-rich conformers independent of prion replication","volume":"30","author":"Resenberger","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.bbadis.2021.166209_bb0395","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.neurobiolaging.2014.02.001","article-title":"A\u03b2 induces its own prion protein N-terminal fragment (PrPN1)-mediated neutralization in amorphous aggregates","volume":"35","author":"B\u00e9land","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.bbadis.2021.166209_bb0400","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1074\/jbc.M112.394528","article-title":"Small misfolded Tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons","volume":"288","author":"Wu","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2021.166209_bb0405","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3389\/fncel.2019.00296","article-title":"Distinct conformations, aggregation and cellular internalization of different tau strains","volume":"13","author":"Karikari","year":"2019","journal-title":"Front. Cell. Neurosci."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443921001423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443921001423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:45:09Z","timestamp":1778769909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443921001423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":81,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0925443921001423"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2021.166209","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurotoxicity of oligomers of phosphorylated Tau protein carrying tauopathy-associated mutation is inhibited by prion protein","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2021.166209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166209"}}